Shukra Pharmaceuticals Clarifies Price Movement to BSE

Key Statements

• The company confirms full compliance with Regulation 30 of SEBI LODR Regulations, 2015
• States that all events, information, and corporate actions bearing on operations, performance, or price behavior have been regularly intimated to the Exchange in a timely manner
• Confirms there is no undisclosed price-sensitive information or any impending announcement/corporate event that needs to be shared with investors at this stage
• Attributes the recent share price movement to purely market-driven factors and natural market forces
• Denies any management connection or involvement with the price movement

Company Addresses

Factory Address: 104, 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India

Financial Impact

No financial impact quantified in the disclosure. The company characterizes the price movement as market-driven without specific financial implications disclosed.